SLU-PP-332 UK – Research Compound

Anglo Peptides provides
SLU-PP-332 UK as a research-use compound for legitimate
laboratory and scientific research. SLU-PP-332 is a synthetic small
molecule developed as an agonist of the estrogen-related receptors
ERRα, ERRβ and ERRγ, making it a useful chemical tool for investigating
ERR signalling and related biological pathways.

Unlike conventional peptide products in the catalogue, SLU-PP-332 is a
small-molecule research compound. This distinction is important when
evaluating its chemical characteristics, scientific literature and
appropriate research applications.

What Is SLU-PP-332?

SLU-PP-332 is a synthetic agonist targeting the three known estrogen-related
receptor subtypes: ERRα, ERRβ and ERRγ. The compound was developed through
structure-based optimisation of earlier ERR ligand scaffolds, with
particular attention to increasing activity at ERRα.

In the original research describing the compound, SLU-PP-332 demonstrated
activity across all three ERR subtypes, with the strongest activity observed
at ERRα. The researchers subsequently investigated its effects on
mitochondrial function, cellular respiration and exercise-associated
transcriptional pathways.

The original peer-reviewed study is available through

PubMed’s SLU-PP-332 research record
.

SLU-PP-332 and ERR Signalling

Estrogen-related receptors are orphan nuclear receptors involved in the
regulation of genes associated with cellular energy metabolism and
mitochondrial function. ERRα, ERRβ and ERRγ have overlapping but distinct
biological roles, making their pharmacological modulation an active area
of research.

SLU-PP-332 is particularly interesting because it provides researchers with
a chemical tool capable of activating all three ERR subtypes. This allows
experimental investigation of ERR-dependent transcription and downstream
metabolic pathways.

A pharmacology review published in 2026 discusses SLU-PP-332 among the
emerging ERR agonists and provides additional background on the
pharmacology of this compound class.

Read the ERR agonist research review
.

SLU-PP-332 Research Background

Research involving SLU-PP-332 has primarily focused on preclinical models
and laboratory systems. Experimental studies have examined its influence
on mitochondrial respiration, oxidative muscle characteristics and
transcriptional programmes associated with exercise.

In mouse models, researchers have also investigated the compound in
relation to energy expenditure, fatty-acid oxidation and metabolic
parameters. These findings are preclinical and should not be interpreted
as evidence of established human therapeutic effects.

A separate study published in the Journal of Pharmacology and
Experimental Therapeutics examined SLU-PP-332 in mouse models of
metabolic syndrome. The study is useful for understanding the compound’s
preclinical research history.

View the study on PubMed
.

Current Scientific Interest

Interest in SLU-PP-332 continues to extend beyond its original
characterisation. Recent research has examined the compound’s metabolism
and analytical detection, reflecting the growing importance of accurately
identifying emerging ERR agonists.

A 2026 analytical study characterised metabolites of SLU-PP-332 using
liquid chromatography and high-resolution mass spectrometry. Such work
contributes to a better understanding of how the compound is transformed
and detected in laboratory settings.

Researchers can review the recent

SLU-PP-332 analytical research published in Drug Testing and Analysis
.

SLU-PP-332 UK Product Information

Researchers considering an SLU-PP-332 research compound
should review the specific product information provided on this page
before ordering.

Relevant product considerations may include the available quantity,
product presentation, storage information where provided and applicable
fulfilment arrangements.

For information regarding delivery and fulfilment, please review the

Anglo Peptides Shipping Policy
.

SLU-PP-332 and Related Research

Researchers investigating metabolic signalling, mitochondrial biology or
peptide-related research may also find other materials within the Anglo
Peptides catalogue relevant for comparison.

• 
  MOTS-c peptide
  
  – a peptide associated with mitochondrial and metabolic research.
• 
  AOD-9604 peptide
  
  – another research material associated with metabolic research.
• 
  Retatrutide research product
  
  – an investigational compound with a different molecular target profile.
• 
  NAD research product
  
  – a product relevant to research involving cellular and metabolic
  processes.

Explore the complete

research peptide collection

for additional research materials.

Research-Use Considerations

SLU-PP-332 is a preclinical research compound and should be evaluated
according to the scientific literature and experimental context in which
it is being studied.

Results obtained from cell-based experiments or animal models cannot be
assumed to translate directly to humans. Researchers should consult
appropriate scientific literature and institutional protocols when
designing experiments involving SLU-PP-332.

The compound should not be represented as an approved treatment or as a
substitute for an authorised medicine.

Ordering SLU-PP-332 UK

Before placing an order, review the product information available on this
page and ensure that the intended purchase is appropriate for legitimate
research purposes.

Customers and researchers are responsible for ensuring that their purchase,
possession, handling and intended research activities comply with all
applicable laws, regulations and institutional requirements.

To explore the wider catalogue, visit the

Anglo Peptides Shop
.

Research-Use Notice

SLU-PP-332 supplied through Anglo Peptides is presented strictly for
legitimate laboratory and scientific research.

This product is not intended for human consumption, self-administration,
diagnosis, treatment or prevention of disease.

Anglo Peptides does not provide dosing instructions, administration
protocols, treatment recommendations or medical advice. Researchers are
responsible for ensuring that their activities comply with applicable
legal, regulatory and institutional requirements.

Explore SLU-PP-332 UK

Review the available SLU-PP-332 product information and explore related
research materials within the Anglo Peptides catalogue.

View SLU-PP-332

Browse Research Peptides